Abdul Mannan/LinkedIn
Sep 17, 2025, 10:22
Abdul Mannan: Turning Medical Podcasts into Active Learning with Structured Tools
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared on LinkedIn:
”We all listen to medical podcasts but sometimes struggle to retain and apply the key points?
I decided to experiment with a more structured approach:
- Professional transcription software for accurate text
- Generated detailed summary with clear action points
- Created organized notes using systematic algorithms
- Embedded the original research PDF alongside the audio track
The result? A complete learning package that transforms passive listening into active knowledge building.
Yes, it takes more time upfront, but the depth of understanding and retention is remarkable. Everything is now accessible, searchable, and ready for future reference.
Sometimes the extra effort in processing information pays dividends in how we actually use and remember it.
Try this and give me your feedback.”
Check here for more information.
Stay informed with Hemostasis Today.
-
Jun 4, 2026, 05:42Subramamyam Penubaku: Early Recognition and Risk-Based Management of Acute Pulmonary Embolism
-
Jun 4, 2026, 05:30Raghavendra Rao: Early Endothermal Ablation and Contemporary Management of Superficial Venous Thrombosis
-
Jun 4, 2026, 05:18Fouad Mikhail: Mechanical Thrombectomy and Anticoagulation in Intermediate-Risk Pulmonary Embolism
-
Jun 3, 2026, 17:18Giacomo Rossi: Cysteine and Gut Health – MIT Finds the Switch
-
Jun 3, 2026, 17:00Amin Ullah: Presence of RBCs of Unequal Sizes in a Peripheral Blood Smear – Anisocytosis of RBC
-
Jun 3, 2026, 16:59Jean Connors: Discussing Cancer-Associated Thrombosis at the Japanese Society of Thrombosis and Hemostasis
-
Jun 3, 2026, 16:54Ayush Bhowmik: Failed Drug Became the World’s Most Widely Used Blood Thinner
-
Jun 3, 2026, 16:13Salvador Payán Pernía: Arguing against a Significant Role for Erythropoietin Analogues in the Management of PRCA
-
Jun 3, 2026, 16:08Pedro Henrique Las Casas: How Anticoagulant Agents and Quercetin Influence Cancer Cell Procoagulant Activity